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Biotin-(strept)avidin complex is widely used in
biotechnology because of its extremely high binding
constant, but there is no report describing spatio-
temporally controlled formation of the complex in
live cells. Here, based on X-ray crystal structure anal-
ysis and calorimetric data, we designed and synthe-
sized photoreleasable biotins, which show greatly
reduced affinity for (strept)avidin, but recover native
affinity after UV irradiation. For application at the
cell surface, we introduced an amine-reactive moiety
into these ‘‘caged’’ biotin molecules. Specific fluo-
rescence imaging of live cells that had been labeled
with these agents and then UV-irradiated, was ac-
complished by addition of streptavidin conjugated
with a fluorophore. We also demonstrated the appli-
cability of these compounds for UV-irradiated-cell-
specific drug delivery by using caged-biotin-labeled
cells, a prodrug, and streptavidin conjugated with
a prodrug-activating enzyme.
INTRODUCTION
Biotin is a water-soluble small molecule (MW 244) that works
as a cofactor for several carboxylases (Figure 1A). Although
the biological functions and biosynthetic pathway of biotin
are still under investigation (Stanley et al., 2001; Lin et al.,
2010), biotin is one of the most widely used molecules in bio-
technology, in combination with its partner protein, (strept)
avidin. Avidin is a tetrameric and basic (pI 10) glycoprotein
found in egg white, consisting of 128 amino acids per subunit.
Streptavidin, which is also a tetrameric protein isolated from
Streptomyces avidinii, does not possess a sugar moiety and
its isoelectric point is near neutral, resulting in less nonspecific
binding to other molecules. The physiological roles of these
proteins are not well known, but it is thought that they act as
a defense against bacteria by inactivating bacterial enzymes
that require biotin as a cofactor (Diamandis and Christopoulos,
1991).Chemistry & Biology 18, 1261–1Biotin-(strept)avidin complex is extensively used in the life
sciences. In fact, biotinylation of DNAs, proteins, and other
biomolecules is the first choice for separation or visualization
of the molecules themselves or their binding partners (Wilchek
and Bayer, 1988; McMahon, 2008). The reasons why the
biotin-avidin complex has been so widely used are that the
complex has an extremely high affinity (Ka 1015 M1) and
that the complex formation is nearly unaffected by pH, tempera-
ture, organic solvents, or denaturing agents (Sakahara and Saga,
1999; Green, 1963). In addition, the tetrameric structure of avidin
allows it to bind simultaneously to biotin groups on the target and
to other biotinylated molecules, such as reporter enzymes. This
multiple binding property readily allows for signal amplification,
which provides increased sensitivity. Notably, in all of these
applications, the carboxyl group of the biotin side chain is chem-
ically linked to biological molecules, and the complex between
the biotin derivatives and (strept)avidin is formed immediately
upon addition of the protein (Yamaguchi et al., 2010). In other
words, the formation of the complex is automatic and depends
only on the presence of the two molecules.
On the other hand, a few researchers have controlled this
complex formation in a stimulus-responsive manner by chemical
modification of biotin, mainly in order to site-specifically immobi-
lize proteins while retaining their biological activities (Lee et al.,
2002; Hengsakul and Cass, 1996). This was done by precoating
the surface of a chip with deactivated biotin containing a photo-
labile protecting group (Sundberg et al., 1995; Pirrung and
Huang, 1996), or an electrochemically removable protecting
group (Kim et al., 2004); these intentionally deactivated biotin
derivatives are called caged biotins in this paper due to the
conceptual analogy with caged biomolecules (Ellis-Davies,
2007), such as caged glutamate and caged ATP. Subsequently,
selected sites of the chip are activated by irradiation through
a photo mask or by electrochemical perturbation; then the
surface is exposed to a solution of a target protein labeled with
avidin to be immobilized on the activated sites. In these reports,
however, although themethodology appears general, neither any
application of the caged biotins to live cells, nor detailed struc-
tural and thermodynamical analysis of the complexes between
caged biotins and avidin was described. Considering that the
biotin-avidin complex is widely used in biochemistry, either
in vitro or in cell culture, we thought that it would be very useful
to extend the range of application of caged biotins to live cells.272, October 28, 2011 ª2011 Elsevier Ltd All rights reserved 1261
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Figure 1. Schematic Illustration of Caged Biotin and Some of Its Applications
(A) Chemical structure of biotin.
(B) Conceptual illustration of caged biotin. Caged biotin can strongly bind to (strept)avidin only after photoirradiation.
(C) Strategy for specific fluorescence labeling of irradiated cells by use of streptavidin conjugated with a fluorophore and pretargeted caged biotin (application 1),
and for irradiated-cell-specific drug delivery by combined use of a prodrug, streptavidin conjugated with an enzyme, and pretargeted caged biotin (application 2).
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biotin-(strept)avidin complexes that could be used in live cells.
Based on structural information about the essential structure of
biotin for protein binding, we synthesized model compounds
modified at the urea nitrogen. All of them had remarkably lower
binding constants than the parent compound. Encouraged
by these results, we developed photoactivatable caged biotin
derivatives that were modified with photocleavable groups at
the urea nitrogen, and showed that they recovered the original
binding affinity for avidin after UV irradiation (Figure 1B). We
then designed and synthesized novel caged biotin derivatives
that could label lysine residues of cell-surface proteins. To
confirm the utility of these compounds, we performed three
experiments, i.e., specific cell-surface fluorescence labeling,
enzyme-mediated nuclear staining, and prodrug-dependent
killing of UV-irradiated cells labeled with the synthesized com-
pounds, using streptavidin conjugated to a fluorophore or a
hydrolytic enzyme. These experiments are illustrated schemati-
cally in Figure 1C.
RESULTS
Biotin Derivatives Modified at the Urea Moiety
For rational development of caged biotins, it is important to know
which part of the biotin structure is essential for the affinity. First,1262 Chemistry & Biology 18, 1261–1272, October 28, 2011 ª2011 Ewe considered this point based on the results of X-ray crystallog-
raphy of biotin-avidin complex (Pugliese et al., 1993). Figure 2A is
a magnified view of the biotin-binding pocket of the complex,
showing biotin as a ball and stick model. The interaction of the
ligand and the protein was analyzed by Molegro Molecular
Viewer software (Molegro ApS, Denmark), and the contribution
of each atom to the total stabilization energy was evaluated.
Namely, the size of the ball corresponds to the importance of
the atom for the affinity. The N0-1 urea nitrogen (yellow arrow-
head), in addition to urea oxygen, was suggested to be the
most important, while N0-3 nitrogen, the methylene linker of the
pentanoic acid moiety, and sulfur atom appeared not to play
major roles. Also, although the carboxylic acid moiety forms
hydrogen bonds with protein amino acids, modification to amide
or ester has little effect on the binding affinity (Sugawara et al.,
1997). Considering the synthetic difficulty of modifying urea
oxygen, we decided to introduce substituents at the N0-1 posi-
tion to block the affinity of biotin for (strept)avidin.
As model compounds, we designed and synthesized three
biotin derivatives with acetyl and alkyl groups at N0-1 (Fig-
ure 2B): monoAc-biotin, monoZ-biotin, and diMe-biotin (see
Supplemental Experimental Procedures, available online, for
synthetic details). We then determined the binding constants
(Ka) of the derivatives with avidin by means of isothermal titra-
tion calorimetry (ITC) (Figure 2C). Indeed, the Ka values of thelsevier Ltd All rights reserved
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Figure 2. The Effect of Introduction of Alkyl and Acetyl Groups at the Urea Moiety of Biotin
(A) Interaction between biotin and avidin. The biotin-binding pocket of avidin is shown in detail. The crystal structure was derived from Protein Data Bank 1AVD,
and analyzed byMolegro software. In this figure, carbon is shown in white, oxygen in red, nitrogen in blue, and sulfur in yellow. The yellow arrowhead indicates the
N0-1 position, and green dotted lines indicate hydrogen bonds.
(B) ITC experiments on biotin derivatives with modified urea moieties. Heat effects were recorded as a function of time during 15 successive 2 ml injections of
800 mM solution of monoAc-biotin, monoZ-biotin or diMe-biotin into the cell containing either 15 mM solution of avidin or buffer solution. Buffer conditions: 0.1 M
sodium phosphate, 0.4% DMSO (pH 7.4).
(C) Thermodynamic parameters of biotin derivatives modified at the urea moiety, determined by ITC.
(D) Overall structures of the complexes between biotin derivatives and avidin. In these figures, avidin subunit A is shown in white as a space-filling model, and
subunit B in yellow as a wire model of central carbon atoms. The biotin-binding pocket is highlighted by a red square.
(E)Closeupviewof the interfacebetweensubunitsAandC.SubunitC isshown inyellowasawiremodelofcentralcarbonatoms.Trp110ofsubunitC isshown inpurple.
Biotin is shown in red stick and avidin is shown as a semitransparent surface. The black arrow in the right figure indicates the direction of viewpoint of the left figure.
See also Figures S1 and S2 and Table S1.
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Caged-Biotin Protein-Labeling Agentscomplexes were dramatically decreased (monoZ-biotin 2.3 3
106 M1, monoAc-biotin 2.0 3 105 M1, diMe-biotin 5.5 3
106 M1 and 4.0 3 108 M1, respectively), being as much as
1091010-fold lower than that of the native complex. Curiously,
the number of binding sites of monoZ-biotin to avidin tetramer
was two, whereas the number in the case of other derivatives,
including native biotin itself, was four. Furthermore, unlike the
other compounds, diMe-biotin bound to avidin in two steps,Chemistry & Biology 18, 1261–1implying the presence of two different binding sites. The results
suggested the possibility that the overall protein conformation
might be altered by ligand binding, or that these ligands bind
to avidin at different sites from the biotin-binding pocket. To
address these questions, we crystallized the complexes from
sodium-citrate buffer containing ammonium sulfate (Figure 2D;
see also Table S1; Figures S1 and S2A–S2D). Notably, we found
that the microstirring technique improved the quality of the272, October 28, 2011 ª2011 Elsevier Ltd All rights reserved 1263
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tion plates with a rotating shaker at 50 rpm (Adachi et al.,
2004; Shimizu et al., 2009). As shown in Figure 2D, the binding
sites of all the biotin derivatives were the same as that of biotin,
thus excluding the second possibility. Also, the position of the
main carbon chain of avidin in these complexes was almost
the same as that of biotin-avidin complex. When the binding
site was magnified, however, it was clear that the binding pocket
in avidin was larger in the complexes of the novel derivatives, in
particular monoZ-biotin, than in the case of biotin. This was due
to the movement of protein side chains so as to accommodate
bulky substituents in the pocket, which resulted not only in reor-
ganization of the delicate hydrogen-bonding network of the
native complex (Pazy et al., 2002), but also in weaker hydro-
phobic interactions between these biotin derivatives and aro-
matic residues of the protein. Especially, Trp110 of the adjacent
subunit, the residue that plays a pivotal role in stabilizing the
tetrameric structure of the complex (Laitinen et al., 1999; Laitinen
et al., 2003), was not able to completely occupy the space
formed at the biotin pocket (Figure 2E). In this sense, the crystal
structures explain the significantly lowerKa values of biotin deriv-
atives with avidin. However, in contrast to the results of ITC, all
the biotin derivatives bound to the protein with a stoichiometry
of 4:1. Although further investigation is necessary, the discrep-
ancy may be attributed to the difference between the experi-
mental conditions of ITC and those of X-ray crystallography,
such as buffer composition and protein concentration. Another
possibility is that the results of ITC reflect the kinetics of the
binding, that is, only the first two monoZ-biotin molecules bind
rapidly to the protein, followed by slow conformational change
that allows for the binding of the other two.
Fluorescence polarization (FP) assay was also carried out to
obtain information about the binding sites. To measure FP, we
synthesized biotin derivatives that were conjugatedwith a fluoro-
phore at the carboxylate moiety through a short linker (see
Supplemental Experimental Procedures for synthetic details).
The value of FP was clearly increased when avidin was added
to solutions of the biotin derivatives, corresponding to the protein
binding of the derivatives (Figure S2E). Importantly, the value
decreased to the original level when excess native biotin was
added to the assay mixture. The data indicated that the biotin
derivatives bind to the same biotin pocket in avidin as native
biotin, even though the binding constants were much lower.
Taken together, these results demonstrate for the first time
that modification at the biotin urea moiety can reduce the affinity
for avidin by approximately 1091010 fold. So, modification at
this site should be widely available to design biotin derivatives
that do not bind to avidin.
Development of Caged Biotins
We next designed and synthesized two photoactivatable biotin
derivatives: NPC-biotin and DMNPE-biotin (Figure 3A; see
Supplemental Experimental Procedures for synthetic details),
which were expected to exhibit a drastic increase of binding
constant upon photoirradiation, owing to release of native biotin
(Sundberg et al., 1995). These compounds consist of biotin and
a nitrobenzyl-based photo-removable protecting group that can
be excited at 365 nmwith a high uncaging rate and a high photol-
ysis quantum yield (Gee et al., 1998). First, to confirm photore-1264 Chemistry & Biology 18, 1261–1272, October 28, 2011 ª2011 Elease of biotin, HPLC analysis of NPC-biotin was performed
before and after photo-irradiation (365 nm, 20 min, 2.8 mW/cm2).
Under this condition, conversion of the starting compound to
the expected product proceeded smoothly without any apparent
by-product formation; the reaction yield was approximately
90% (Figure S3A).We next determined theKa values of the deriv-
atives and avidin by ITC (Figures 3B–3D). As expected, the
Ka values of the complexes were drastically decreased (NPC-
biotin: 1.5 3 104 M1, DMNPE-biotin: 1.3 3 104 M1) compared
with that of native biotin. Moreover the binding constant of the
two derivatives to avidin recovered to the value of native biotin
after photoirradiation. Note that the number of binding sites of
caged biotin after photoirradiation was estimated to be some-
what higher than that of native complex because a small amount
of the starting compound was still present in the mixture.
To probe the structural details of the interaction between
caged biotin and avidin, we solved the structure of the avidin
complex with NPC-biotin at 2.0 A˚ resolution (Table S1; Figures
S1 and S3B). Consistent with the results in the previous section,
the overall binding mode of NPC-biotin was similar to that of
biotin, with Trp110 in the neighboring subunit partially interacting
with the biotin pocket (Figure 3E). The biotin pocket was also
expanded to approximately the same size as that in the case
of monoZ-biotin, and the bulky protecting group inhibited both
the hydrophobic and hydrogen-bonding interactions between
the ligand and the protein.
Specific Fluorescence Labeling of Irradiated Cells
As the first application of these caged biotins in live cells, we
devised a method for specific fluorescence labeling of irradiated
cells by combined use of fluorophore-conjugated streptavidin
and pretargeted caged biotin. First, as illustrated in Figure 4A,
proteins on the cell surface are labeled with caged biotin via a
covalent amide bond. Then the target cells are UV irradiated,
followed by the addition of fluorophore-conjugated streptavidin.
Only at the site of irradiation, where the strong affinity of native
biotin is recovered as a result of uncaging, should the fluores-
cence of streptavidin be detected. To realize this strategy, we
designed and synthesized amine-reactive caged biotins, NPC-
biotin-linker-SE and DMNPE-biotin-linker-SE (Figure 4A; see
Supplemental Experimental Procedures for synthetic details).
In these compounds, succinimidyl ester was introduced as a
reactive moiety able to form a covalent bond with the amino
group of lysine residues of the surface proteins. The compounds
were loaded into cultured HeLa cells, and 30 min later, the cells
were irradiated and mixed with streptavidin conjugated with
AlexaFluor488. Unbound streptavidin was washed out before
imaging. As shown in Figure 4B, a strong fluorescence signal
was only observed from the irradiated sample, which supports
the feasibility of the strategy. The mean fluorescence intensity
of the irradiated cells was approximately 50 times higher than
that of nonirradiated cells with either NPC-biotin or DMNPE-
biotin as the caged biotin, as determined by flow cytometry (Fig-
ure 4C; see also Figure S4A). As shown in Figure 4D, the rate of
uncaging of DMNPE-biotin was slightly higher than that of NPC-
biotin. The amounts of energy required to uncage half of the
caged biotin were 0.24 J/cm2 (NPC-biotin) and 0.17 J/cm2
(DMNPE-biotin), respectively. The background fluorescence
from streptavidin that bound to caged biotin without irradiationlsevier Ltd All rights reserved
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Figure 3. Development of Caged Biotins that Recover Full Affinity for Avidin Only after Photoirradiation
(A) Scheme of photodegradation process of caged biotins.
(B) ITC experiment with NPC-biotin before and after photoirradiation. Heat effects were recorded as a function of time during 15 successive 2 ml injections of
3.3 mM solution of NPC-biotin into the cell containing either 56 mM solution of avidin or buffer solution (as control). After irradiation of NPC-biotin solution for
20 min, heat effects were recorded again as a function of time during 15 successive 2 ml injections of 500 mM solution of the irradiated sample into the cell
containing either 10 mM solution of avidin or buffer solution. Buffer conditions: 0.1 M sodium phosphate, 0.4% DMSO (pH 7.4).
(C) Isothermal titration calorimetry of DMNPE-biotin before and after photoirradiation. The experimental conditions were the same as described above.
(D) ITC parameters of caged biotins modified at the urea moiety.
(E) Overall structures of the complexes between NPC-biotin and avidin. In the figure, avidin subunit A is shown in white as a space-filling model, and subunit B in
yellow as a Ca wire model. The biotin-binding pocket is highlighted by a red square. A closeup view of the interface between subunits A and C is also shown.
Subunit C is shown in yellow as a Cawiremodel. Trp110 of subunit C is shown in purple. Biotin is shown in red stick. Avidin is shown as a semitransparent surface,
and the biotin pocket of avidin is highlighted.
See also Figures S1 and S3 and Table S1.
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Figure 4. Specific Fluorescence Labeling of Irradiated Cells Using Caged Biotin Derivatives
(A) Strategy for specific fluorescence labeling of irradiated cells by combined use of streptavidin conjugated with a fluorophore and pretargeted caged biotin. The
chemical structure of the labeling agent, caged biotin-linker-SE, is also shown.
(B) Epi-fluorescence and DIC images of HeLa cells that were labeled by NPC-biotin and subsequently treated with streptavidin-conjugated AlexaFluor488.
Irradiation was performed for 5 min (2.8 mW/cm2), before the addition of streptavidin-Alexa488. ng#1 to 3 represent control cells without streptavidin-Alexa488,
light irradiation, and NPC-biotin, respectively.
(C) The mean fluorescence intensity of 10,000 cells treated with caged biotin, streptavidin-conjugated AlexaFluor488 and with/without irradiation, analyzed by
flow cytometry.
(D) Relationship between irradiation time and the amount of bound streptavidin conjugated with AlexaFluor488. Uncaging rates were evaluated from the average
fluorescence intensity from flow cytometric analysis, and the half reaction times (t, min) are shown in the inset.
See also Figure S4.
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Figure 5. Cell Viability and Fluorophore Localization of Cells Labeled with Caged Biotin and Streptavidin Conjugated with AlexaFluor488
(A) Cell viability of HeLa cells treatedwith caged biotin, streptavidin, and light irradiation. The left figure shows the viability at 1 hr after the light irradiation. The right
figure shows the viability at 24 hr after the light irradiation. The viability assays were performed with Cell Counting Kit-8 (CCK-8). The error bars indicate the
standard deviation of eight independent experiments.
(B) Bright field (upper panel) and confocal fluorescence (lower panel) images of HeLa cells labeled with DMNPE-biotin and streptavidin-conjugated Alexa-
Fluor488. The images were taken immediately after or 5 hr after the treatment. The size scale bar was 50 mm.
See also Figure S5.
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a weaker background signal than DMNPE-biotin, although the
difference was not large. Considering both the efficiency of un-
caging and the amount of background binding, we mainly used
DMNPE-biotin for subsequent cellular applications. In Figure 4B,
the result of whole-dish irradiation is shown for clarity, but of
course, it was possible to label only cells of interest specifically
in a single dish (Figure S4B).
One concern in using caged biotins is the possible cytotoxicity
of the compounds, especially of the nitroso intermediate (Il’ichev
et al., 2004), as well as that of UV light. Hence, the effect of the
compounds themselves and the effect of irradiation were exam-
ined by means of CCK-8 cell survival assay, soon after the treat-
ment and 24 hr later (Figure 5A). In both cases, caged biotin
showed no significant toxicity, suggesting that it is possible to
label live cells with caged biotin without causing severe damage.
Confocal microscopy (Figure 5B; Figure S5) showed that the
biotin/streptavidin complex remained localized on the cell sur-
face immediately after the labeling and 5 hr later, although a
part of the complex might have been transported inside cells
within 5 hr. Taken together, these results indicate that it is
feasible to use the caged biotin system to track cells for a period
of at least several hours.
Application for Photoirradiated Cell-Specific Nuclear
Staining
As a second application, we conceived an antibody-directed
enzyme prodrug therapy (ADEPT)-like strategy (Dubowchik
andWalker, 1999) for specific nuclear staining of irradiated cells,
by combined use of streptavidin conjugated with b-galactosi-
dase, Hoechst-Obgal and pretargeted caged biotin (Figure 6A).
Hoechst33258 is a nuclear staining fluorophore widely used in
live cells (Figure 6B) (Breusegem et al., 2002). The compound,
having cationic character and a planar aromatic system, inter-
acts noncovalently with negatively charged double-stranded
DNA or RNA byminor groove binding. Although the fluorescence
of free Hoechst is extremely low in aqueous solution, when itChemistry & Biology 18, 1261–1binds to nucleic acids, a huge increase in fluorescence quantum
yield occurs due to the stabilization of planar conformation
(Barooah et al., 2011).
On the other hand, derivatives of the nuclear staining dyes that
bear bulky substituents generally emit relatively weak fluores-
cence, presumably because of a less favorable binding to DNA
(Koide et al., 2009). Therefore we derivatized Hoechst33258
with a bulky and hydrophilic b-galactoside moiety to yield an
enzymatically activatable prodrug, Hoechst-Obgal (Figure 6B;
see also Figure S6A; seeSupplemental Experimental Procedures
for synthetic details), which exhibited a dramatic increase of
fluorescence in live cells after hydrolysis by b-galactosidase.
First, we confirmed that the fluorescence intensity of Hoechst
was approximately 15 times higher than that of Hoechst-Obgal
in live cells (Figure 6C). Next, fluorescence imageswere captured
after Hoechst-Obgal loading of cells that had been incubated
with NPC or DMNPE-biotin-linker-SE for 30 min, irradiated
with a UV lamp, and mixed with streptavidin conjugated with
b-galactosidase. The average fluorescence intensity of the cells
exposed to photo-irradiation was higher than that without irradi-
ation (4.4-fold for NPC-biotin, and 3.5-fold for DMNPE-biotin)
(Figure 6D; see also Figure S6B). As compared with the contrast
ratio of approximately 45-fold in the previous section, the values
of the ratio in this experiment are not very satisfactory. A plausible
factor is the presence of an unexpected background signal
derived from the nonirradiated sample (Figure S6C), which sug-
gests the presence of streptavidin conjugated with b-galactosi-
dase that was nonspecifically bound to caged biotin on the cell
surface. Analogous results were obtained using a fluorescent
substrate of b-galactosidase, as well (Figures S6D and S6E).
Application for Photoirradiation-Specific Induction
of Cell Death
As the third application, we developed a system of irradiated cell-
specific induction of cell death by combined use of an antican-
cer prodrug, streptavidin conjugated with b-galactosidase, and
pretargeted caged biotin (Figure 7A). We selected doxorubicin272, October 28, 2011 ª2011 Elsevier Ltd All rights reserved 1267
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Figure 6. Photoirradiated Cell-Specific Nuclear Staining Using Hoechst-Obgal
(A) Strategy for irradiated cell-specific nuclear staining by combined use of streptavidin conjugated with b-galactosidase and pretargeted caged biotin.
(B) Reaction scheme of Hoechst-Obgal with b-galactosidase.
(C) Epi-fluorescence images of HeLa cells incubated with Hoechst-Obgal (left) or native Hoechst (right). The size scale bar is 50 mm.
(D) DIC (left) and epi-fluorescence (right) images of HeLa cells treated with DMBPE-biotin, streptavidin conjugated with b-galactosidase, Hoechst-bgal, and with
and without light irradiation. The size scale bar is 50 mm.
See also Figure S6.
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tercalating DNA (Minotti et al., 2004), and is effective against
proliferating cells. We synthesized a prodrug, DXR-bgal (Fig-
ure 7B), in which b-galactose and DXR are linked by a car-
bamate spacer (Devalapally et al., 2007) (see Supplemental
Experimental Procedures for synthetic details). The IC50 of DXR-
bgal was expected to be markedly larger than that of DXR
itself, because the derivative should not interact with DNA, as dis-
cussed above for Hoechst-Obal. Cytotoxicity assay was per-
formed after incubation of the compounds for 24 hr, followed by
an additional 24 hr incubation. The IC50 of DXR was calculated
to be 79 nM while that of DXR-bgal was 13 mM (Figure S7). Next,
to evaluate the induction of cell death using caged biotin, HeLa
cells were incubated with caged-biotin-linker-SE for 30 min, illu-
minatedwithUV light, and incubatedwith streptavidin conjugated
with b-galactosidase for 10 min. Then, DXR-bgal was loaded into
the medium for 24 hr, and the cells were incubated for an addi-
tional 24 hr without the compound. As determined by CCK-8
assay, approximately 45% of the irradiated cells remained alive
(p < 0.01 versus unirradiated cells by Student’s t test), while no
significant difference was observed between nonirradiated cells
and control cells (Figure 7C). Although there is room for improve-
ment as to the percentage of dead cells, it is clear that specific
induction of cell death of photoirradiated cells was achieved.
DISCUSSION
Although (strept)avidin-biotin interaction is universally used in
biology, it is not suitable for every application. For example,1268 Chemistry & Biology 18, 1261–1272, October 28, 2011 ª2011 Ethe dissociation constant of the order of 1015 is too strong for
affinity purification and very harsh conditions are required to
elute the biotin-conjugated molecules, which sometimes leads
to alteration of the native function or conformation of the targets.
To solve this problem, two approaches have been mainly em-
ployed: mutation of the proteins and derivatization of biotin. In
the former approach, avidin and streptavidin with a mutation
at W110 and W120, respectively, were found to have lower
binding affinity to biotin (Ka 108 M1). Interruption of intersub-
unit contacts was suggested to be the cause (Laitinen et al.,
1999; Sano and Cantor, 1995), though no structural data were
provided. The crystal structures in this study are the first struc-
tural data to demonstrate the importance of the Trp residue.
As to the latter approach, several compounds, including desthio-
biotin (Hirsch et al., 2002), 2-iminobiotin (Fudem-Goldin and Orr,
1990), and HABA (Green, 1970), which act as reversible binders
to (strept)avidin, have been developed. Our results here suggest
that introduction of substituents at N0-1 would be an alternative
way to attenuate the binding affinity to realize reversible binding,
because some of our compounds showed moderate affinity
in the range of Ka 106 M1. Because the origin of the over-
whelming binding affinity of the avidin-biotin complex has
attracted attention in the fields of computational (Tong et al.,
2010), medicinal (Kuhn and Kollman, 2000) and supermolecular
(Rekharsky et al., 2007) chemistry, the present results should
be of wide interest.
Another potential problem with native (strept)avidin-biotin
complex is the multivalency, which might lead to aggregation
or functional interference with molecules of interest. To addresslsevier Ltd All rights reserved
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directed mutation (Laitinen et al., 2003; Qureshi and Wong,
2002; Howarth et al., 2006). Interestingly, the results of our ITC
experiments shown in Figure 2 imply that only two monoZ-biotin
molecules bind to avidin in solution, and this might provide a clue
to allow the development of a monovalent avidin complex
through the synthesis of novel biotin derivatives.
As noted above, the idea of caged biotin itself is not original to
this work. However, biological application of caged biotin to
cells, e.g., for site-specific fluorescence labeling and drug
delivery, is unprecedented to our knowledge. As compared
with caged fluorophores (Kobayashi et al., 2007), the fluores-
cence labeling systemdeveloped in this study has several advan-
tages. First, fluorophores such as Alexa dyes, which do not
possess hydroxyl or amino groups, as well as large fluorescent
entities such as quantum dots, can be used. Second, by means
of successive irradiation and incubation, it would be possible to
achieve multicolor labeling. Third, in comparison with caged
fluorophores, the streptavidin-conjugated fluorophores used in
this strategy are more readily available.
For our last two applications, we selected b-galactosidase as
the enzyme, because of its high catalytic turnover, stability, avail-
ability, and the established usage in reporter gene assay (Silver-
man et al., 1998) and ADEPT (Dubowchik and Walker, 1999). In
biology and medicine, there is a huge demand to deliver chem-
icals only to selected cells/tissues. Various methodologies
have been developed for this purpose, including a gene expres-
sion-dependent system (Greco and Dachs, 2001), an antibody-
dependent system (Dubowchik andWalker, 1999), and an irradi-
ation-dependent method (Ellis-Davies et al., 2007). Compared
with them, the method introduced in this study has many advan-
tages; for example, (1) it does not require troublesome transfec-
tion or expensive antibody, (2) active compounds can be catalyt-
ically produced, (3) spatial specificity even down to the single cell
level could theoretically be obtainable, and (4) damage to theChemistry & Biology 18, 1261–1cells seems to be negligible. A remaining problem with the
current system is the nonspecific binding of streptavidin conju-
gated with b-galactosidase to the surface of nontarget cells.
Among various approaches that we tried to obviate this, washing
with diluted acetic acid was most effective to decrease the
background, but it may be possible to further reduce it by
changing the enzyme or method of conjugation. It should also
be pointed out that the suboptimal difference of cell survival
between irradiated and unirradiated cells shown in Figure 7C is
partially due to the cytotoxic activity of uncleaved DXR-bgal
itself, so this issue might be overcome by the use of other drugs.
Of course, lateral diffusion of the active molecule is an inherent
drawback of all caged compounds, and this release system is
no exception. However, we believe there may be ways to
decrease the effect, including three-dimensional culture of cells.
Because this is the first study using caged biotins in live cells,
the applications shown here represent proofs of concept, and
may need further development. We would like to emphasize,
however, that the scope of potential biological applications of
caged biotin-streptavidin pairs is very wide. For instance,
a variety of natural or synthetic molecules such as receptor
agonists/antagonists, growth factors, chemokines, and MRI or
PET imaging agents, could be specifically localized on the
surface of cells of interest, to decipher the complex machinery
of living systems. We hope that this study will provide the stim-
ulus for developing a broad range of applications of caged
biotins.
SIGNIFICANCE
We investigated in detail the affinity for avidin of biotin
derivatives modified at the urea moiety, and found for the
first time that modification at this site generally reduced
the affinity by 1091010-fold, compared with native biotin.
The X-ray structures of these complexes were solved, and272, October 28, 2011 ª2011 Elsevier Ltd All rights reserved 1269
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Caged-Biotin Protein-Labeling Agentsthe results suggested that themodificationperturbsboth the
electrostatic andhydrophobic interactions of theprotein and
ligand. Based on the results, we developed photoreleasable
caged biotins that could be used to label the surface of live
cells.
To demonstrate the utility of these compounds, we carried
out site-specific fluorescence labeling of cultured cells with
high contrast, by means of photoirradiation of cells labeled
with caged biotin in the presence of streptavidin-conjugated
fluorophores. Moreover, we successfully demonstrated nu-
clear staining and induction of cell death specifically in
photo-irradiated cells. In combination with other kinds of
fluorophores, biologically active compounds, or enzymes,
these biotin derivatives should serve as potentially useful
tools in various fields of biology.
EXPERIMENTAL PROCEDURES
Protein Crystallization
Avidin from egg white was purchased from Wako Pure Chemical Industries.
Avidin was crystallized at a protein concentration of 10 mg/ml by the sitting-
drop vapor method in 2.5–2.7 M ammonium sulfate with 0.1 M sodium citrate
(pH 4.0–5.0) with continuous stirring (Adachi et al., 2004). The protein solutions
were crystallized at 293 K, and the crystal growth vessels (Hampton Research)
were covered with 0.08 mm thick sealing tape (JT Science). The volume of the
protein drops was 2 ml.
X-Ray Diffraction
X-ray diffraction experiments were performed under liquid-nitrogen-cooled
conditions at 100 K. An avidin crystal was mounted in a nylon loop, soaked
briefly in cryoprotectant solution and then frozen by rapidly submerging it in
liquid nitrogen. X-ray diffraction data were collected at beamline BL44XU of
the SPring-8 synchrotron-radiation source (Harima, Japan). Diffraction data
were processed and scaled using HKL-2000. The data collection and process-
ing statistics are summarized in Table S1.
Structure Determinations and Refinements
The deposited structure coordinates for avidin P42212 form crystal (PDB ID
code 1AVD) were used as a starting model for the structural analysis. Struc-
tural refinements were carried out using a stereochemically constrained
least-squares refinement method in the CNS program package and Refmac
software (Murshudov et al., 1999) as implemented within the CCP4 package
(Collaborative Computational Project, Number 4, 1994). Refinement statistics
are depicted in Table S1.
ITC Analysis
Isothermal titration calorimetry experiments were carried out with an ITC200
(Microcal, Inc.). Calorimeters were electrically calibrated according to the
manufacturer’s instructions. Protein or a chemical compound was loaded
into the calorimeter cell as described in the text. The titration syringe was
loaded with another reactant at 10- to 20-fold greater concentration than in
the cell. Titrations were usually carried out using 10–15 injections of 15 ml or
10 ml each injected at 150 s intervals. Stirring was performed at 1000 rpm as
suggested by themanufacturer. Titrations were carried out at 30C. Both reac-
tants were dissolved in the same solution containing 100 mM sodium phos-
phate (pH 7.4), as described in the text.
Flow Cytometric Analysis
HeLa cells (1 3 105 cells/ml) were cultured overnight in DMEM on a 35 mm
glass-bottomed cell culture dish (Matsunami Corp.). The medium was
removed after 24 hr, and the cells were washed three times with 1 ml of
PBS. Then a Hank’s balanced salt solution (HBSS) buffer (Invitrogen Corp.)
(700 ml) containing 5 mM NPC or DMNPE-biotin-linker SE (0.1% DMSO as a
cosolvent) was added and the cells were incubated for 30 min at 37C. The
cells were then washed twice with PBS (1 ml), and illuminated with a high-1270 Chemistry & Biology 18, 1261–1272, October 28, 2011 ª2011 Epressure UV lamp (SLUV-4, Asone) at 365 nm. After illumination, 2 mM strepta-
vidin conjugated with AlexaFluor 488 in 1 ml of HBSS was added and the cells
were incubated for 10 min at room temperature. After having been washed
twice with PBS (1 ml), the cells were trypsinized, pelleted, resuspended in
DMEM and, if necessary, the cell suspensions were mixed. Then the fluores-
cence of the cells was analyzed by a BD LSR II flow cytometer (Becton Dick-
inson). Every experiment was done several times.
Epi-Fluorescence Imaging of Specific Fluorescence Labeling
of Irradiated Cells
HeLa cells (1 3 105 cells/ml) were cultured on a 35 mm glass-bottomed cell
culture dish (Matsunami Corp.) and cultured overnight in DMEM. The medium
was removed after 24 hr, and the cells were washed three times with 1 ml of
PBS. Then a Hank’s balanced salt solution (HBSS) buffer (Invitrogen Corp.)
(700 ml) containing 20 mM NPC or DMNPE-biotin-linker SE (0.1% DMSO as
a cosolvent) was added and the cells were incubated for 30 min at 37C.
The cells were then washed twice with PBS (1 ml), and illuminated with
a high-pressure mercury lamp (BH2-RFL-T3, Olympus) via a 330–385 nm
band-pass filter (BP330-385, Olympus) through the objective lens (UPlanFL
N 403, Olympus) of a fluorescence microscope (IX71, Olympus). After illumi-
nation, 6 mM streptavidin conjugated with AlexaFluor 488 in 1 ml of HBSS
was added and the cells were incubated for 10 min at room temperature.
The cells were then washed twice with PBS (1 ml), and the fluorescence
images were acquired with an IX71 imaging system (Olympus) equipped
with a cooled CCD camera (Coolsnap HQ, Photometrics), using a xenon
lamp (AH2-RX-T, Olympus) with a BP 470-490 excitation filter and a BA
510–550 emission filter. Every experiment was done twice.
Confocal Imaging of Specific Fluorescence Labeling of Irradiated
Cells
Essentially the same procedure as above was employed. We used a confocal
imaging system (TCS-SP5X; Leica) equipped with a white light laser. Fluores-
cence images were captured using a Leica Application Suite Advanced Fluo-
rescence (LAS-AF) with a 103 objective lens. The excitation wavelength was
488 nm and emission was collected in the range of 510–550 nm.
Cytotoxicity Assay
HeLa cells (5 3 103 cells/well) were cultured overnight in DMEM on a 96-well
plate (Thermo Scientific, AB-1100/k). The medium was removed after 24 hr,
and the cells were washed three times with PBS. Then a Hank’s balanced
salt solution (HBSS) buffer (Invitrogen Corp.) (100 ml) containing 5 mM NPC
or DMNPE-biotin-linker SE (0.1% DMSO as a cosolvent) was added and the
cells were incubated for 30 min at 37C. The cells were then washed twice
with PBS, and illuminatedwith a UV lamp (SLUV-4, Asone) at 365 nm. After illu-
mination, 6 mM streptavidin in HBSS was added and the cells were incubated
for 10 min at room temperature. The cells were then washed with PBS, 0.1%
acetic acid solution, and PBS, successively. The irradiated cells were incu-
bated for 24 hr after treatment and the medium was replaced with 100 ml of
DMEM containing 10% Cell Counting Kit-8 (DOJINDO). Cells were incubated
for another 1–4 hr and the absorbance at 440 nm was measured using a SH-
8000 plate reader (Corona Electric). Absorbance at 650 nmwas alsomeasured
and the value was subtracted as the background. Values of the wells contain-
ing cells without biotin derivatives, streptavidin or light treatment was set as
corresponding to fully alive, and values of the wells without cells were set as
blank. Every experiment was done several times.
Cell Assay with Hoechst-Obgal
HeLa cells (1 3 105 cells/ml) were cultured overnight in DMEM on a 35 mm
glass-bottomed cell culture dish (Matsunami Corp.). The medium was
removed after 24 hr, and the cells were washed three times with 1 ml of
PBS. Then a Hank’s balanced salt solution (HBSS) buffer (Invitrogen Corp.)
(700 ml) solution containing 5 mM NPC or DMNPE-biotin-linker SE (0.1%
DMSO as a cosolvent) was added and the cells were incubated for 30 min
at 37C. The cells were then washed twice with PBS (1 ml), and illuminated
with a UV lamp (SLUV-4, Asone) at 365 nm. After illumination, 600 nM strepta-
vidin conjugated with b-galactosidase in 1 ml of HBSS was added and the
cells were incubated for 10 min at room temperature. Then the cells were
washed with PBS, 0.1% acetic acid, and PBS, successively. Hoechst orlsevier Ltd All rights reserved
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Caged-Biotin Protein-Labeling AgentsHoechst-Obgal (20 mM, 1 ml) was added and fluorescence images were
acquired with anIX71 imaging system (Olympus, Japan) equipped with a
cooled CCD camera (Coolsnap HQ, Photometrics), using a xenon lamp
(AH2-RX-T, Olympus) with a BP 330–385 excitation filter and a BP 460–495
emission filter. Every experiment was done several times.
Cell Assay with DXR-bgal
HeLa cells (5 3 103 cells/well) were cultured overnight in DMEM on a 96-well
plate (Thermo Scientific, AB-1100/k). The medium was removed after 24 hr,
and the cells were washed twice with PBS. Then a Hank’s balanced salt solu-
tion (HBSS) buffer (100 ml) solution containing 5 mM NPC or DMNPE-biotin-
linker SE (0.1%DMSOas a cosolvent) was added and the cells were incubated
for 30min at 37C in the dark. The cells were then washed twice with PBS, and
illuminated with a mercury handy UV lamp at 365 nm. After illumination, strep-
tavidin conjugated with b-galactosidase (0.6 mM, 100 ml) in HBSS was added
and the cells were incubated for 10 min at room temperature. The cells were
then washed with PBS, 0.1% acetic acid, and PBS again. Doxorubicin or
doxorubicin-bgal (10 mM, 100 ml) in HBSS was added to the medium and the
cells were incubated for 24 hr. After the treatment, the cells were incubated
for another 24 hr, then the medium was replaced with 100 ml of DMEM con-
taining 10% Cell Counting Kit-8 (DOJINDO). Cells were incubated for another
1–4 hr and the absorbance at 440 nm was measured using a SH-8000 plate
reader (Corona Electric Co., Ltd.). Absorbance at 650 nm was also measured
and the value was subtracted as the background. Values of the wells contain-
ing cells without biotin derivatives, streptavidin, or light treatment was set as
corresponding to fully alive, and values from the wells without cells were set
as blank. Every experiment was done several times.ACCESSION NUMBERS
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